1. Home
  2. TKLF vs LEXX Comparison

TKLF vs LEXX Comparison

Compare TKLF & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yoshitsu Co. Ltd

TKLF

Yoshitsu Co. Ltd

N/A

Current Price

$1.60

Market Cap

8.4M

ML Signal

N/A

Logo Lexaria Bioscience Corp.

LEXX

Lexaria Bioscience Corp.

N/A

Current Price

$4.60

Market Cap

9.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TKLF
LEXX
Founded
2006
2004
Country
Japan
Canada
Employees
N/A
7
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.4M
9.5M
IPO Year
2020
2011

Fundamental Metrics

Financial Performance
Metric
TKLF
LEXX
Price
$1.60
$4.60
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
9.6K
★ 48.5K
Earning Date
12-18-2026
11-27-2026
Dividend Yield
★ 17.01%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $705,923.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$6,915.00
P/E Ratio
$2.82
★ N/A
Revenue Growth
N/A
★ 52.05
52 Week Low
$1.30
$0.35
52 Week High
$3.49
$21.60

Technical Indicators

Market Signals
Indicator
TKLF
LEXX
Relative Strength Index (RSI) 47.29 61.49
Support Level $1.30 $2.67
Resistance Level $1.64 $10.26
Average True Range (ATR) 0.12 0.43
MACD 0.01 0.26
Stochastic Oscillator 40.89 90.67

Price Performance

Historical Comparison
TKLF
LEXX

About TKLF Yoshitsu Co. Ltd

Tokyo Lifestyle Co Ltd is a retailer and wholesaler of Japanese beauty and health products, sundry products, electronic products, and other products. It sells its products through directly operated physical stores, online stores, and franchise stores and wholesale customers. It operates through directly operated physical stores, online stores and services, and franchise stores and wholesale customers segments, with the franchise stores and wholesale customers segment generating maximum revenue. Geographically, it generates maximum revenue from Hong Kong.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.

Share on Social Networks: